PT1173194E - Sp-a recombinante para o tratamento ou a prevencao da infeccao e da inflamacao pulmonares - Google Patents

Sp-a recombinante para o tratamento ou a prevencao da infeccao e da inflamacao pulmonares

Info

Publication number
PT1173194E
PT1173194E PT00912431T PT00912431T PT1173194E PT 1173194 E PT1173194 E PT 1173194E PT 00912431 T PT00912431 T PT 00912431T PT 00912431 T PT00912431 T PT 00912431T PT 1173194 E PT1173194 E PT 1173194E
Authority
PT
Portugal
Prior art keywords
inflammation
prevention
treatment
recombinant
pulmonary
Prior art date
Application number
PT00912431T
Other languages
English (en)
Inventor
Klaus Melchers
Klaus P Schafer
Wolfram Steinhilber
Jeffrey A Whitsett
Ann Marie Levine
Thomas R Korfhagen
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of PT1173194E publication Critical patent/PT1173194E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT00912431T 1999-01-19 2000-01-18 Sp-a recombinante para o tratamento ou a prevencao da infeccao e da inflamacao pulmonares PT1173194E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15526899P 1999-01-19 1999-01-19

Publications (1)

Publication Number Publication Date
PT1173194E true PT1173194E (pt) 2004-10-29

Family

ID=22554732

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00912431T PT1173194E (pt) 1999-01-19 2000-01-18 Sp-a recombinante para o tratamento ou a prevencao da infeccao e da inflamacao pulmonares

Country Status (11)

Country Link
US (2) US7135452B1 (pt)
EP (1) EP1173194B1 (pt)
AT (1) ATE269101T1 (pt)
AU (1) AU774207B2 (pt)
CA (1) CA2361276A1 (pt)
DE (1) DE60011601T2 (pt)
DK (1) DK1173194T3 (pt)
ES (1) ES2223478T3 (pt)
PT (1) PT1173194E (pt)
SI (1) SI1173194T1 (pt)
WO (1) WO2000043026A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1276495B1 (en) * 2000-04-12 2006-04-19 ALTANA Pharma AG Use of recombinant pulmonary surfactant for the early treatment of acute pulmonary diseases
SE0203591D0 (sv) * 2002-12-04 2002-12-04 Siemens Elema Ab Förfarande för beredning av ett mediakament och en medicinsk anordning
WO2007111496A1 (en) * 2006-03-28 2007-10-04 Universiteit Utrecht Holding B.V. Improved carbohydrate recognition domains
JP5554702B2 (ja) * 2007-06-05 2014-07-23 パカ パルモナリー ファーマシューティカルズ， インコーポレイテッド 薬剤を肺に送達するための方法および組成物
US9289388B2 (en) 2008-12-10 2016-03-22 Paka Pulmonary Pharmaceuticals, Inc. Methods and compositions for delivery of medicaments to the lungs
CA2854437A1 (en) * 2010-11-04 2012-05-10 The Board Of Regents Of The University Of Oklahoma Peptide compositions that downregulate tlr-4 signaling pathway and methods of producing and using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659805A (en) * 1984-12-11 1987-04-21 California Biotechnology, Inc. Recombinant alveolar surfactant protein
US4912038A (en) * 1984-12-11 1990-03-27 California Biotechnology Inc. Recombinant DNA sequence encoding alveolar surfactant protein
US5840527A (en) 1984-12-11 1998-11-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Recombinant alveolar surfactant protein
US4882422A (en) * 1985-10-24 1989-11-21 Genetics Institute, Inc. Pulmonary surfactant proteins
WO1988005820A1 (en) * 1987-01-29 1988-08-11 California Biotechnology, Inc. Recombinant alveolar surfactant protein
JP3961029B2 (ja) 1992-06-24 2007-08-15 博 木戸 インフルエンザウィルス感染防止剤
US6267958B1 (en) * 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation

Also Published As

Publication number Publication date
US7135452B1 (en) 2006-11-14
WO2000043026A3 (en) 2001-10-18
EP1173194B1 (en) 2004-06-16
SI1173194T1 (en) 2004-12-31
ATE269101T1 (de) 2004-07-15
DK1173194T3 (da) 2004-10-18
ES2223478T3 (es) 2005-03-01
DE60011601T2 (de) 2005-07-07
US20060194732A1 (en) 2006-08-31
AU3420900A (en) 2000-08-07
AU774207B2 (en) 2004-06-17
CA2361276A1 (en) 2000-07-27
DE60011601D1 (de) 2004-07-22
EP1173194A2 (en) 2002-01-23
WO2000043026A2 (en) 2000-07-27

Similar Documents

Publication Publication Date Title
CY1108007T1 (el) Φαρμακευτικες συνθεσεις βοτουλινικης τοξινης
IT1318649B1 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
IS5191A (is) Örverueyðandi hindrun og meðferð gegn eyðniveirunni og öðrum smitsjúkdómum í mönnum
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
BR0007597A (pt) Composição hipoalergênica contendo peptìdios tolerogênicos induzindo tolerância oral
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
CY1114133T1 (el) ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ γ-ΦΑΙΝΥΛ-Δ-ΛΑΚΤΑΜΕΣ ΚΑΙ ΧΡΗΣΕΙΣ ΠΟΥ ΣΧΕΤΙΖΟΝΤΑΙ ΠΡΟΣ ΑΥΤΕΣ
DK1153610T3 (da) Matrixproteinpræparater til inflammatoriske og infektiøse tilstande
DK1095061T3 (da) Peptider baseret på sekvensen af humant lactoferring og deres anvendelse
SE9904377D0 (sv) Pharmaceutical combinations
DE60025026D1 (de) Antimicrobielle wirkung des ersten kationischen cluster des menschlichen lactoferrins
BR9710899A (pt) Composição compreendendo mupirocin e clorohexidina.
PT1173194E (pt) Sp-a recombinante para o tratamento ou a prevencao da infeccao e da inflamacao pulmonares
YU39598A (sh) Upotreba duloksetina i njegova farmaceutska smeša
AU2002325169A1 (en) Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases
AU4568400A (en) Sphingomyelinase inhibitor
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
HUP0203321A2 (hu) (6-Metoxi-2-naftil)-ecetsav prodrug készítmények gyulladás kezelésére
PT1276495E (pt) Utilizacao de tensioactivo pulmonar recombinante para o tratamento precoce de doencas pulmonares agudas
ATE401337T1 (de) Antiangiogene polypeptide
PT1052991E (pt) Utilizacao de loperamida para o tratamento de infeccoes microbianas
EE200000694A (et) Inimese rekombinantse iterferooni beeta-1a (IFN-ß-1a) formulatsioon
DE60003074D1 (de) Fusidinsäure-derivate
BR0013665A (pt) Uso de uma proteìna histacalina, composição farmacêutica, e, método de tratar ou impedir conjuntivite